Broadfin Capital’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $7.77M | Sell |
1,029,012
-2,073,661
| -67% | -$15.7M | 1.04% | 24 |
|
2019
Q3 | $12.9M | Hold |
3,102,673
| – | – | 2.39% | 10 |
|
2019
Q2 | $8.97M | Hold |
3,102,673
| – | – | 1.95% | 15 |
|
2019
Q1 | $4.47M | Hold |
3,102,673
| – | – | 0.92% | 33 |
|
2018
Q4 | $8.01M | Buy |
3,102,673
+309,900
| +11% | +$800K | 1.05% | 24 |
|
2018
Q3 | $12.3M | Buy |
2,792,773
+68,110
| +2% | +$299K | 1.8% | 18 |
|
2018
Q2 | $16.7M | Buy |
2,724,663
+100,000
| +4% | +$613K | 2.63% | 13 |
|
2018
Q1 | $19.1M | Buy |
2,624,663
+32,942
| +1% | +$240K | 2.98% | 12 |
|
2017
Q4 | $21.3M | Sell |
2,591,721
-976,401
| -27% | -$8.01M | 3.47% | 13 |
|
2017
Q3 | $37.5M | Sell |
3,568,122
-565,342
| -14% | -$5.94M | 5.54% | 5 |
|
2017
Q2 | $45.6M | Sell |
4,133,464
-261,000
| -6% | -$2.88M | 5.54% | 4 |
|
2017
Q1 | $42.5M | Hold |
4,394,464
| – | – | 5.15% | 4 |
|
2016
Q4 | $45.7M | Hold |
4,394,464
| – | – | 5.07% | 5 |
|
2016
Q3 | $54.5M | Hold |
4,394,464
| – | – | 4.88% | 5 |
|
2016
Q2 | $47.2M | Hold |
4,394,464
| – | – | 4.59% | 5 |
|
2016
Q1 | $48.5M | Hold |
4,394,464
| – | – | 4.69% | 3 |
|
2015
Q4 | $53.7M | Hold |
4,394,464
| – | – | 3.3% | 7 |
|
2015
Q3 | $71.7M | Sell |
4,394,464
-580,720
| -12% | -$9.47M | 3.99% | 3 |
|
2015
Q2 | $105M | Buy |
4,975,184
+255,225
| +5% | +$5.41M | 5.67% | 2 |
|
2015
Q1 | $84.9M | Sell |
4,719,959
-433,231
| -8% | -$7.79M | 6.61% | 2 |
|
2014
Q4 | $88.3M | Buy |
5,153,190
+147,577
| +3% | +$2.53M | 7.68% | 2 |
|
2014
Q3 | $71.6M | Sell |
5,005,613
-262,298
| -5% | -$3.75M | 7.51% | 1 |
|
2014
Q2 | $79M | Hold |
5,267,911
| – | – | 7.71% | 1 |
|
2014
Q1 | $70.6M | Buy |
5,267,911
+1,500,000
| +40% | +$20.1M | 6.84% | 1 |
|
2013
Q4 | $30.3M | Hold |
3,767,911
| – | – | 4% | 7 |
|
2013
Q3 | $24.7M | Buy |
3,767,911
+628,780
| +20% | +$4.12M | 4.39% | 6 |
|
2013
Q2 | $19.3M | Buy |
+3,139,131
| New | +$19.3M | 3.77% | 9 |
|